基于竞技病毒的载体在非人类灵长类动物中产生强大的SIV免疫力
Bhawna Sharma1, Elena Bekerman1, Hoa Truong1
1Gilead Sciences, Inc., Foster City, CA 94404, USA.
Vaccines
|July 27, 2024
概括
复制和非复制的竞技病毒载体显示出对艾滋病毒治疗的希望. 这些载体在非人类灵长类动物中引起强烈的T细胞和B细胞免疫反应,支持对类免疫缺陷病毒 (SIV) 疫苗的进一步临床评估.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 病毒载体技术 病毒载体技术
背景情况:
- 基于Arenavirus的载体正在成为治疗疫苗的有希望的候选者.
- 这些载体有可能诱导显著的CD8T细胞反应,这对于对抗HIV等病毒感染至关重要.
研究的目的:
- 为了比较表达猿类免疫缺陷病毒 (SIV) 抗原的复制和非复制的竞技病毒载体的免疫性.
- 在非人类灵长类动物中评估同源与异源原始增强方案的疗效.
主要方法:
- 非人类灵长类动物接受了复制 (artPICV,artLCMV) 或非复制 (rPICV,rLCMV) 编码SIV Gag和Env免疫原体的竞技病毒载体.
- 通过测量SIV特异性干扰素- (IFN-γ) 反应和抗Env抗体标位来评估免疫性.
- 对比了不同的免疫路线 (静脉注射和肌肉内注射) 和方案 (同源和异源).
主要成果:
- 异质疗法诱导的SIV IFN-γ反应比同源疗法更强大.
- 与非复制载体相比,复制载体引起的细胞免疫性显著更高.
- 异质方案的静脉注射导致高的抗Env抗体标位,复制载体显示出优越的诱导.
- 肌肉内免疫对两种载体类型的免疫导致比静脉内免疫更持久的抗体反应.
结论:
- 复制和非复制的竞技病毒载体都有效地产生T细胞和B细胞对非人类灵长类动物SIV抗原的免疫力.
- 这些发现支持进一步的临床开发的阿雷纳病毒载体作为治疗艾滋病毒的疫苗.
- 异质原始提升策略和复制载体的使用可能会提高疫苗的疗效.
相关概念视频
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...


